Daily non-political popular news in brief.

Cholesterol-lowering drugs and the risk of hemorrhagic stroke

12-12-2007 · EurekAlert!

People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke. The research is published in the Dec. 12, 2007, online issue of Neurology, the medical journal of the American Academy of Neurology.

Keywords: cholesterol-lowering, drugs, risk, hemorrhagic, stroke, cholesterol, lowering, drug

« Previous | Next »

Similar news on "Cholesterol-lowering drugs and the risk of hemorrhagic stroke":

Stopping statins after stroke raises risk of death, dependency
08-27-2007 · EurekAlert!
People who stopped taking cholesterol-lowering drugs after being hospitalized for a stroke are at greater risk of death or dependency within three months of the stroke, according to a study published in the Aug. 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Similar news · Read more »
Patients who stop using statins after stroke increase risk of death
08-30-2007 · EurekAlert!
Patients who stop taking cholesterol-lowering drugs within a year of surviving a stroke had a two-fold increased risk of death, researchers reported in Stroke: Journal of the American Heart Association.
Similar news · Read more »
Cholesterol-lowering drugs reduce risk of stroke, heart attack
05-02-2007 · EurekAlert!
People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28-May 5, 2007.
Similar news · Read more »
Statins defend against fungus-caused sepsis
10-14-2006 · Science News Online
Cholesterol-lowering drugs called statins might reduce the risk of dying from sepsis triggered by a fungal infection.
Similar news · Read more »
Statin therapy slows progression of arterial thickening; halts but does not reverse atherosclerosis
03-25-2007 · EurekAlert!
Among low-risk middle-aged people with subclinical atherosclerosis, the cholesterol-lowering drug rosuvastatin reduces the rate of progression of arterial thickening and stops but does not reverse atherosclerotic disease, according to a study in the March 28 issue of JAMA. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
Similar news · Read more »
Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
06-11-2007 · EurekAlert!
Slicing certain pills in half could slice a hefty amount off of Americas prescription drug costs. While only some types of pills can be split safely, they include popular cholesterol-lowering drugs. Now, the first prospective randomized controlled trial of pill-splitting gives more evidence of how the practice could be used.
Similar news · Read more »
Study shows risk of acute pancreatitis low with statins
12-28-2006 · EurekAlert!
New research reveals that while cholesterol-lowering drugs do increase the risk of painful inflammation of the pancreas, the side effect is relatively rare, according to Sonal Singh, M.D., from Wake Forest University School of Medicine, and colleagues.
Similar news · Read more »
New strategy to cut heart attack risk is effective in initial test
12-17-2007 · EurekAlert!
The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.
Similar news · Read more »
Annals of Internal Medicine tip sheet for July 3, 2007, issue
07-02-2007 · EurekAlert!
In this issue: Dietary counseling results in weight loss of approximately six percent of body weight after one year; Annals of Internal Medicine is 80! -- Still young and still reaching out; High dose of cholesterol-lowering drug reduces risk for major cardiovascular events in older as well as younger patients; Beta-blockers reduce plaque in artery walls; and Cystatin C level predicts death risk from three causes as well as usual tests.
Similar news · Read more »
University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
01-09-2008 · EurekAlert!
Medical researchers at the University of Alberta in Edmonton, Canada have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of diabetes and heart disease related to obesity. Existing drugs called statins are used to lower cholesterol, but do not treat obesity or diabetes.
Similar news · Read more »